Hepatic mediators of lipid metabolism and ketogenesis: focus on fatty liver and diabetes.
CONCLUSION: A better understanding of the molecular mediators involved in lipid synthesis and ketogenesis can lead to new treatments for metabolic disorders in the liver, such as NAFLD.
PMID: 33143628 [PubMed - as supplied by publisher]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Fernandes GW, Bocco BMLC Tags: Curr Diabetes Rev Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Hepatocellular Carcinoma | Insulin | Liver | Liver Cancer | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Pancreas | Pancreatic Cancer | Urology & Nephrology
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024